Aspect Biosystems Financed by e@UBC Seed Fund!

Published on Wednesday, August 20, 2014


Aspect Biosystems supplies drug development companies with human tissue samples designed specifically to be used in the testing of new drugs.  Aspect has developed an unique capability for engineering structured tissues from donor human cells.  The company deploys a proprietary 3D printing technology to build their tissue products on demand.

e@UBC has worked closely with Aspect and we’re proud to announce our continued support for them thru an investment in the company from the e@UBC seed fund.  

Aspect is a graduate of e@UBC’s Lean Launch Pad for Genomics (2013).

Register now to gain access to our programs and resources, including our Accelerator programs!